0 Image Tablet Side1
Allergy Relief Tablet
Product Images NDC 73581-201
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Allergy Relief (NDC 73581-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Yyba Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
0 Image Tablet Side2
01b Lbl_allergy Relief_180mg_df1 (01b Lbl Allergy Relief 180mg Df1)
Not available. The text seems to be incomplete and contains many errors.*
01b Lbl_allergy Relief_180mg_df2 (01b Lbl Allergy Relief 180mg Df2)
This appears to be a drug information label. The drug is called "sevy," and it is suggested for use as a treatment for severe symptoms. The label includes usage directions for both adults and children as well as information about inactive ingredients. The product is not recommended for pregnant or nursing women. If you have any questions or concerns, you are encouraged to contact the manufacturer. Store the product at room temperature, and do not use if the safety seal is broken. Not available.*
01b Lbl_allergy Relief_180mg_pdp (01b Lbl Allergy Relief 180mg Pdp)
The text appears to be a description of a medication called "Welmate" that provides allergy relief, specifically to temporarily alleviate symptoms such as runny nose, sneezing and watery eyes. The medication contains Levocatirizine Dihydrochloride, with a dosage of 5 mg that provides 24-hour relief. However, the text is incomplete as it seems to be cut off and the last line appears to be random characters.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
